Innate Pharma announces clinical data presentations on IPH5401 and monalizumab at ESMO 2019

NEXT STORY
In-vitro Diagnostics Market To Exhibit a CAGR of 4.5%; Adoption Of New Techniques For Rapid Disease Diagnosis Will Encourage Growth, says Fortune Business Insights
PREV STORY
BeiGene Announces Clinical Results on Tislelizumab Presented at the 22nd Annual Meeting of the Chinese Society of Clinical Oncology (CSCO)
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Clearside Biomedical Announces Multiple Oral Presentations Delivered at the American Society of Retinal Specialists (ASRS) Annual Meeting

author_avatar
NASDAQ Market News

Iovance Biotherapeutics Reports Second Quarter and First Half 2021 Financial Results and Corporate Updates

author_avatar
NASDAQ Market News

Advanced Accelerator Applications Reports 32% Sales Growth for Second Quarter 2017

Positive CHMP Opinion for Lutetium Lu 177 Dotatate* (Lutathera®) for GEP-NETS FDA Acknowledged Receipt ...

author_avatar
NASDAQ Market News